A number of major drugmakers have reportedly raised the prices of hundreds of brand-name drugs, including some of the manufacturers that made deals with the Trump administration to lower prices.

The reporters have investigated pharmacy benefit managers and prescription drug prices. The spending package passed by Congress on Tuesday includes an effort to drive down drug prices, by imposing new restrictions on some of the most controversial practices of the giant companies that oversee prescription benefits.

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the federal government to haggle directly with drug manufacturers NEW YORK -- Drugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug price negotiation program that allows the federal government to haggle directly with drug manufacturers, the Trump administration said Tuesday.